BCL2 and hepatocellular carcinoma: In human hepatocellular carcinoma, esculetin induced apoptosis in SMMC-7721 cells by activating caspase 3 and caspase 9, promoting Bax expression, decreasing BCL-2 expression, triggering collapse of mitochondrial membrane potential, and increasing cytochrome c release from mitochondria.